Aug 09, 2016 9:00am EDT Ekso Bionics Holdings Announces Uplisting to Nasdaq Capital Market and Pricing of $15 Million Offering of Common Stock
Jul 26, 2016 5:39pm EDT Ekso Bionics to Report Second Quarter 2016 Financial Results on July 28, 2016
Jul 07, 2016 4:03pm EDT Ekso Bionics™ to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Jun 07, 2016 6:00am EDT EKSO Bionics Robotic Exoskeletons Gain Global Connectivity With Vodafone IoT Technology
May 10, 2016 7:00am EDT Ekso Bionics® To Showcase First FDA Cleared Exoskeleton Approved for Use with Stroke Patients at 9th World Congress for NeuroRehabilitation (WCNR)
May 04, 2016 4:31pm EDT Ekso Bionics announces 1-for-7 Reverse Stock Split in preparation for Proposed Uplisting to NASDAQ
